(NASDAQ:ARGX – Get Free Report) was upgraded by investment analysts at Sanford C. Bernstein from a “market perform” rating to ...

Jones Financial Companies Lllp increased its holdings in argenx SE (NASDAQ:ARGX – Free Report) by 1,016.7% during the fourth ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 13.80%, which has investors questioning if this is right time to buy.

Autoimmune, pemphigus, dermatology, medical odyssey, oral health mystery, oral health, blisters, OASIS, Lupus, Sjogren's, ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin.

The first direct visual evidence of the supermassive black hole in the centre of Messier 87 and its shadow. Event Horizon ...

Artiva Biotherapeutics’ CEO Fred Aslan, MD, identifies data points the company is prioritizing to demonstrate that results from certain trials will translate to similar efficacy across a range of ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, explains the strategic advantages of pursuing both a company-sponsored trial and an investigator-initiated trial simultaneously.

When humans bite their nails, it’s usually dismissed as a nervous tick or a bad habit. At worst, it is thought of as impolite ...

as well as Principia-partnered BTK inhibitor rilzabrutinib for rare autoimmune skin disease pemphigus. It also abandoned an mRNA-based vaccine for COVID-19 and suffered delays to another COVID-19 ...